Association of IL-6 gene polymorphisms and COPD in a Spanish Population

Respiratory Medicine

Volumn 102, Issue 12, 2008, Pages 1805-1811

  Córdoba Lanús, Elizabeth ^a   de Torres, Juan Pablo ^a   López Aguilar, Celeste ^a   Rodríguez Pérez, María Cristo ^a   Maca Meyer, Nicole ^a   Montejo de Garcini, Angela ^a   Aguirre Jaime, Armando ^a   Pérez Méndez, Lina ^a   Casanova, Ciro ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

COPD; Haplotype; Interleukin 6; Pathogenesis; Polymorphism

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROL GROUP; DISEASE MARKER; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MUSCLE FUNCTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; SPAIN; SPIROMETRY;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 55649093513     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.06.012     Document Type: Article

References (32)

1. Lokke A., Lange P., Scharling H., Fabricius P., and Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 61 (2006) 935-939
2. Eid A.A., Lonescu A.A., Nixon L.S., Lewis-Jenkins V., Matthews S.B., Griffiths T.L., et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1414-1418
3. de Torres J.P., Cordoba-Lanus E., Lopez-Aguilar C., Muros de Fuentes M., Montejo de Garcini A., Aguirre-Jaime A., et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 27 (2006) 902-907
4. Agustí A.G.N., Noguera A., Sauleda J., Sala E., Pons J., and Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21 (2003) 347-360
5. Donaldson G.C., Seemungal T.A., Patel I.S., Bhowmik A., Wilkinson T.M., Hurst J.R., et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128 (2005) 1995-2004
6. Broekhuizen R., Wouters E.F., Creutzberg E.C., and Schols A.M. Raised CRP levels mark metabolic and functional impairment in advance COPD. Thorax 61 (2006) 17-22
7. Sin D.D., Lacy P., York E., and Man S.F. Effects of flucticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 760-765
8. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and association with systemic onset juvenile arthritis. J Clin Invest 102 (1998) 1369-1376
9. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., and Miller G.J. The interleukin-6 -174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22 (2001) 2243-2252
10. Vickers M.A., Green F.R., Terry C., Mayosi B.M., Julier C., Lathrop M., et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 53 (2002) 1029-1034
11. Ferrari D.L., Ahn-Luong L., Garnero P., Humphries S.E., and Greenspan S.L. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88 (2003) 255-259
12. Seifart C., Dempfle A., Plagens A., Seifart U., Clostermann U., Müller B., et al. TNF-α, TNF-β, IL-6, and IL-10 promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 65 (2005) 93-100
13. Broekhuizen R., Grimble R.F., Howell W.M., Shale D.J., Creutzberg E.C., Wouters E.F., et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism. Am J Clin Nutr 82 (2005) 1059-1064
14. Pauwels R.A., Buist A.S., Ma P., Jenkins C.R., and Hurd S.S. Gold Scientific Committee. Global strategy for the diagnosis, management and, prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
15. Quanjer P.H. Standardized lung function testing. Report of the Working Party for the European Community for Steel and Coal. Bull Eur Physiopathol Respir Suppl. 5 (1983) 22-27
16. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., and Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23 (2004) 28-33
17. Cabrera de León A., González D.A., Méndez L.I., Aguirre-Jaime A., del Cristo Rodríguez Pérez M., Coello S.D., et al. Leptin and altitude in the cardiovascular diseases. Obes Res 12 (2004) 1492-1498
18. Maca-Meyer N., Villar J., Pérez-Méndez L., Cabrera de León A., and Flores C. A tale of aborigines, conquerors and slaves: Alu insertion polymorphism ante peopling of Canary Islands. Ann Hum Genet 68 (2004) 600-605
19. Garcia-Closas M., and Lubin J.H. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol 149 (1999) 689-692
20. Raymond M., and Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenecism. J Hered 86 (1995) 248-249
21. Barret J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
22. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genet 73 (2003) 1162-1169
23. Nyholt D.R. A simple correction for multiple testing for SNPs in linkage disequilibrium with each other. Am J Hum Genet 74 (2004) 765-769
24. Bennermo M., Held C., Green F., Strandberg L.E., Ericsson C.G., Hansson L.O., et al. Prognostic value plasma interleukin-6 concentrations and the -174G > C and -572G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 174 (2004) 157-163
25. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., et al. Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma inteleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21 (2001) 1458-1463
26. Shin K.K., Jang Y., Koh S.J., Kim O.Y., Choi D., Shin D.J., et al. Influence of the IL-6 -572C > G polymorphism on inflammatory markers according to cigarette smoking in Korean healthy men. Cytokine 39 (2007) 116-122
27. Terry C.F., Louckaci V., and Green F.R. Cooperative influence of genetic polymorphism on interleukin 6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144
28. Müller-Steinhardt M., Frickle L., Müller B., Ebel B., Kirchner H., and Härtel C. Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572 and -174 on long term kidney allograft survival. Am J Transplant 4 (2004) 402-406
29. Snider G.L. Understanding inflammation in chronic obstructive pulmonary disease: the process begins. Am J Respir Crit Care Med 167 (2003) 1045-1046
30. van Helvoort H.A., Heijdra Y.F., Heunks L.M., Meijer P.L., Ruitenbeek W., Thijs H.M., et al. Supplemental oxygen prevents exercise-induced oxidative stress in muscle-wasted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 (2006) 1122-1129
31. Joppa P., Petrasova D., Stancak B., and Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 130 (2006) 326-333
32. Yokoe T., Minoguchi K., Matsuo H., Oda N., Minoguchi H., Yoshino G., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134